if the patients who discontinued therapy for drug-related reasons are considered , the percentages of patients with clinically satisfactory blood pressure reductions were 59 % for the guanabenz group versus 62 % for the propranolol group and 79 % for guanabenz-treated patients versus 64 % for pindolol-treated patients .
C0020649
blood
C0033497
propranolol